Cargando…
Hearing Impairment and Neuroimaging Results in Mitochondrial Diseases
Mitochondrial diseases (MDs) are heterogeneous genetic disorders characterized by mitochondrial DNA (mtDNA) defects, involving tissues highly dependent on oxidative metabolism: the inner ear, brain, eye, skeletal muscle, and heart. We describe adult patients with genetically defined MDs, characteriz...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10532611/ https://www.ncbi.nlm.nih.gov/pubmed/37763097 http://dx.doi.org/10.3390/jpm13091329 |
_version_ | 1785112001592164352 |
---|---|
author | Cadoni, Gabriella Primiano, Guido Picciotti, Pasqualina M. Calandrelli, Rosalinda Galli, Jacopo Servidei, Serenella Conti, Guido |
author_facet | Cadoni, Gabriella Primiano, Guido Picciotti, Pasqualina M. Calandrelli, Rosalinda Galli, Jacopo Servidei, Serenella Conti, Guido |
author_sort | Cadoni, Gabriella |
collection | PubMed |
description | Mitochondrial diseases (MDs) are heterogeneous genetic disorders characterized by mitochondrial DNA (mtDNA) defects, involving tissues highly dependent on oxidative metabolism: the inner ear, brain, eye, skeletal muscle, and heart. We describe adult patients with genetically defined MDs, characterizing hearing function and neuroimaging results. We enrolled 34 patients (mean age: 50.02 ± 15 years, range: 18–75 years; 20 females and 14 males) classified in four groups: MELAS, MIDD, PEO, and Encephalopathy/Polyneuropathy. Audiological evaluations included psychoacoustical tests (pure-tone and speech audiometry), electrophysiological tests (Auditory Brainstem Responses, ABRs), and Impedenzometry. Neuroimaging evaluations considered global MRI abnormalities or structural brain changes. In total, 19/34 patients carried the m.3243A > G mutation (6 affected by MELAS, 12 affected by MIDD, and 1 affected by PEO); 11 had an mtDNA deletion (all affected by PEO); 3 had nuclear genes associated with MDs (POLG1 and OPA1); and 1 patient had an mtDNA deletion without an identified nuclear gene defect (affected by PEO). Sensory neural, bilateral, and symmetrical hearing loss was present in 25 patients (73.5%) to different degrees: 9 mild, 9 moderate, 5 severe, and 2 profound. The severe/profound and mild hearing losses were associated with pantonal and high-frequency audiograms, respectively. Instead, moderate hearing losses were associated with both high-frequency (five cases) and pantonal (five cases) audiogram shapes. In addition, 21/25 patients showed a cochlear site of lesion (84%), and 4/25 (16%) showed a retrocochlear site. We found global MRI abnormalities or structural brain changes in 26/30 subjects (86.6%): 21 had white matter abnormalities, 15 had cortical atrophy, 10 had subcortical atrophy, 8 had basal nuclei involvement or cerebellar atrophy, 4 had stroke-like lesions or laminar necrosis, and 1 had cysts or vacuolated lesions. We concluded that genetic alterations are associated with different clinical presentations for both auditory function and neuroradiological findings. There is no fixed relationship between genotype and phenotype for the clinical conditions analyzed. |
format | Online Article Text |
id | pubmed-10532611 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-105326112023-09-28 Hearing Impairment and Neuroimaging Results in Mitochondrial Diseases Cadoni, Gabriella Primiano, Guido Picciotti, Pasqualina M. Calandrelli, Rosalinda Galli, Jacopo Servidei, Serenella Conti, Guido J Pers Med Article Mitochondrial diseases (MDs) are heterogeneous genetic disorders characterized by mitochondrial DNA (mtDNA) defects, involving tissues highly dependent on oxidative metabolism: the inner ear, brain, eye, skeletal muscle, and heart. We describe adult patients with genetically defined MDs, characterizing hearing function and neuroimaging results. We enrolled 34 patients (mean age: 50.02 ± 15 years, range: 18–75 years; 20 females and 14 males) classified in four groups: MELAS, MIDD, PEO, and Encephalopathy/Polyneuropathy. Audiological evaluations included psychoacoustical tests (pure-tone and speech audiometry), electrophysiological tests (Auditory Brainstem Responses, ABRs), and Impedenzometry. Neuroimaging evaluations considered global MRI abnormalities or structural brain changes. In total, 19/34 patients carried the m.3243A > G mutation (6 affected by MELAS, 12 affected by MIDD, and 1 affected by PEO); 11 had an mtDNA deletion (all affected by PEO); 3 had nuclear genes associated with MDs (POLG1 and OPA1); and 1 patient had an mtDNA deletion without an identified nuclear gene defect (affected by PEO). Sensory neural, bilateral, and symmetrical hearing loss was present in 25 patients (73.5%) to different degrees: 9 mild, 9 moderate, 5 severe, and 2 profound. The severe/profound and mild hearing losses were associated with pantonal and high-frequency audiograms, respectively. Instead, moderate hearing losses were associated with both high-frequency (five cases) and pantonal (five cases) audiogram shapes. In addition, 21/25 patients showed a cochlear site of lesion (84%), and 4/25 (16%) showed a retrocochlear site. We found global MRI abnormalities or structural brain changes in 26/30 subjects (86.6%): 21 had white matter abnormalities, 15 had cortical atrophy, 10 had subcortical atrophy, 8 had basal nuclei involvement or cerebellar atrophy, 4 had stroke-like lesions or laminar necrosis, and 1 had cysts or vacuolated lesions. We concluded that genetic alterations are associated with different clinical presentations for both auditory function and neuroradiological findings. There is no fixed relationship between genotype and phenotype for the clinical conditions analyzed. MDPI 2023-08-29 /pmc/articles/PMC10532611/ /pubmed/37763097 http://dx.doi.org/10.3390/jpm13091329 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Cadoni, Gabriella Primiano, Guido Picciotti, Pasqualina M. Calandrelli, Rosalinda Galli, Jacopo Servidei, Serenella Conti, Guido Hearing Impairment and Neuroimaging Results in Mitochondrial Diseases |
title | Hearing Impairment and Neuroimaging Results in Mitochondrial Diseases |
title_full | Hearing Impairment and Neuroimaging Results in Mitochondrial Diseases |
title_fullStr | Hearing Impairment and Neuroimaging Results in Mitochondrial Diseases |
title_full_unstemmed | Hearing Impairment and Neuroimaging Results in Mitochondrial Diseases |
title_short | Hearing Impairment and Neuroimaging Results in Mitochondrial Diseases |
title_sort | hearing impairment and neuroimaging results in mitochondrial diseases |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10532611/ https://www.ncbi.nlm.nih.gov/pubmed/37763097 http://dx.doi.org/10.3390/jpm13091329 |
work_keys_str_mv | AT cadonigabriella hearingimpairmentandneuroimagingresultsinmitochondrialdiseases AT primianoguido hearingimpairmentandneuroimagingresultsinmitochondrialdiseases AT picciottipasqualinam hearingimpairmentandneuroimagingresultsinmitochondrialdiseases AT calandrellirosalinda hearingimpairmentandneuroimagingresultsinmitochondrialdiseases AT gallijacopo hearingimpairmentandneuroimagingresultsinmitochondrialdiseases AT servideiserenella hearingimpairmentandneuroimagingresultsinmitochondrialdiseases AT contiguido hearingimpairmentandneuroimagingresultsinmitochondrialdiseases |